Company Performance Metrics
- Gregory F. Molnar: Co-Founder, Chief Science Officer, Vice President, and Vice Chair
Justin Zenanko: Co-Founder, President and CEO, Chair of the Board of DirectorsPast Role: Recombinetics, Chief Financial Officer
SynerFuse is a provider of traditional spine implants intended to offer long-term pain management without the use of addictive opioids. The company's technologies synergistically fuse with traditional spine implants to offer a more efficient and effective solution to long-term pain following back surgery, enabling physicians to improve spine
implant outcomes with a drug-free pain management system.
SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attack the problem of long-term post-surgery lower-back pain, with a preemptive, drug-free pain management system. It’s simple and brilliant. The company makes traditional spine implants more successful and cost-effective by embedding active neuromodulation therapy at the time surgeons are performing fusion back surgery.
SynerFuse was founded in 2015 and is headquartered in Minneapolis, Minnesota, United States.
